Arteritic anterior ischemic optic neuropathy treated with intravenous prostaglandin E1 and steroids

Robert D. Steigerwalt, M. Rosaria Cesarone, Gianni Belcaro, Antonella Pascarella, Mauro De Angelis, Roberto Gattegna, Marcella Nebbioso

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Arteritic anterior ischemic optic neuropathy (AAION) is an acute ischemia of the posterior ciliary arteries and/or ophthalmic artery due to inflammation. Therapy is immediate intervention with systemic steroids, especially to protect against vision loss in the other eye. The addition of a potent vasodilator to the steroids could help restore ocular blood flow and improve visual acuity. The objective of the current report was to present the use of prostaglandin E 1 (PGE1) - a powerful vasodilator of the microcirculation - in the treatment of AAION. Two patients with AAION were treated with intravenous steroids and PGE1. The visual acuity improved from 4/50 (less than 20/200) to 6/10 (20/35) in one patient and from 1/50 (20/400) to 1/10 (20/200) in the second patient. The visual fields in both patients maintained small central islands of vision. No complications due to the use of PGE 1 were seen. Intravenous PGE1 should be considered in addition to steroids in cases of AAION to immediately restore blood flow to the optic nerve and improve visual acuity while the steroids reduce the inflammation.

Original languageEnglish
JournalInternational Journal of Angiology
Volume19
Issue number3
DOIs
Publication statusPublished - Sep 2010

Fingerprint

Ischemic Optic Neuropathy
Alprostadil
Prostaglandins E
Steroids
Visual Acuity
Vasodilator Agents
Ciliary Arteries
Ophthalmic Artery
Inflammation
Microcirculation
Optic Nerve
Visual Fields
Islands
Ischemia
Therapeutics

Keywords

  • AAION
  • Arteritic anterior ischemic optic neuropathy
  • Giant cell arteritis
  • PGE
  • Prostaglandin E

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Steigerwalt, R. D., Cesarone, M. R., Belcaro, G., Pascarella, A., De Angelis, M., Gattegna, R., & Nebbioso, M. (2010). Arteritic anterior ischemic optic neuropathy treated with intravenous prostaglandin E1 and steroids. International Journal of Angiology, 19(3). https://doi.org/10.1055/s-0031-1278380

Arteritic anterior ischemic optic neuropathy treated with intravenous prostaglandin E1 and steroids. / Steigerwalt, Robert D.; Cesarone, M. Rosaria; Belcaro, Gianni; Pascarella, Antonella; De Angelis, Mauro; Gattegna, Roberto; Nebbioso, Marcella.

In: International Journal of Angiology, Vol. 19, No. 3, 09.2010.

Research output: Contribution to journalArticle

Steigerwalt, RD, Cesarone, MR, Belcaro, G, Pascarella, A, De Angelis, M, Gattegna, R & Nebbioso, M 2010, 'Arteritic anterior ischemic optic neuropathy treated with intravenous prostaglandin E1 and steroids', International Journal of Angiology, vol. 19, no. 3. https://doi.org/10.1055/s-0031-1278380
Steigerwalt, Robert D. ; Cesarone, M. Rosaria ; Belcaro, Gianni ; Pascarella, Antonella ; De Angelis, Mauro ; Gattegna, Roberto ; Nebbioso, Marcella. / Arteritic anterior ischemic optic neuropathy treated with intravenous prostaglandin E1 and steroids. In: International Journal of Angiology. 2010 ; Vol. 19, No. 3.
@article{0ec746d3f19a4238a303932308644649,
title = "Arteritic anterior ischemic optic neuropathy treated with intravenous prostaglandin E1 and steroids",
abstract = "Arteritic anterior ischemic optic neuropathy (AAION) is an acute ischemia of the posterior ciliary arteries and/or ophthalmic artery due to inflammation. Therapy is immediate intervention with systemic steroids, especially to protect against vision loss in the other eye. The addition of a potent vasodilator to the steroids could help restore ocular blood flow and improve visual acuity. The objective of the current report was to present the use of prostaglandin E 1 (PGE1) - a powerful vasodilator of the microcirculation - in the treatment of AAION. Two patients with AAION were treated with intravenous steroids and PGE1. The visual acuity improved from 4/50 (less than 20/200) to 6/10 (20/35) in one patient and from 1/50 (20/400) to 1/10 (20/200) in the second patient. The visual fields in both patients maintained small central islands of vision. No complications due to the use of PGE 1 were seen. Intravenous PGE1 should be considered in addition to steroids in cases of AAION to immediately restore blood flow to the optic nerve and improve visual acuity while the steroids reduce the inflammation.",
keywords = "AAION, Arteritic anterior ischemic optic neuropathy, Giant cell arteritis, PGE, Prostaglandin E",
author = "Steigerwalt, {Robert D.} and Cesarone, {M. Rosaria} and Gianni Belcaro and Antonella Pascarella and {De Angelis}, Mauro and Roberto Gattegna and Marcella Nebbioso",
year = "2010",
month = "9",
doi = "10.1055/s-0031-1278380",
language = "English",
volume = "19",
journal = "International Journal of Angiology",
issn = "1061-1711",
publisher = "Thieme Medical Publishers",
number = "3",

}

TY - JOUR

T1 - Arteritic anterior ischemic optic neuropathy treated with intravenous prostaglandin E1 and steroids

AU - Steigerwalt, Robert D.

AU - Cesarone, M. Rosaria

AU - Belcaro, Gianni

AU - Pascarella, Antonella

AU - De Angelis, Mauro

AU - Gattegna, Roberto

AU - Nebbioso, Marcella

PY - 2010/9

Y1 - 2010/9

N2 - Arteritic anterior ischemic optic neuropathy (AAION) is an acute ischemia of the posterior ciliary arteries and/or ophthalmic artery due to inflammation. Therapy is immediate intervention with systemic steroids, especially to protect against vision loss in the other eye. The addition of a potent vasodilator to the steroids could help restore ocular blood flow and improve visual acuity. The objective of the current report was to present the use of prostaglandin E 1 (PGE1) - a powerful vasodilator of the microcirculation - in the treatment of AAION. Two patients with AAION were treated with intravenous steroids and PGE1. The visual acuity improved from 4/50 (less than 20/200) to 6/10 (20/35) in one patient and from 1/50 (20/400) to 1/10 (20/200) in the second patient. The visual fields in both patients maintained small central islands of vision. No complications due to the use of PGE 1 were seen. Intravenous PGE1 should be considered in addition to steroids in cases of AAION to immediately restore blood flow to the optic nerve and improve visual acuity while the steroids reduce the inflammation.

AB - Arteritic anterior ischemic optic neuropathy (AAION) is an acute ischemia of the posterior ciliary arteries and/or ophthalmic artery due to inflammation. Therapy is immediate intervention with systemic steroids, especially to protect against vision loss in the other eye. The addition of a potent vasodilator to the steroids could help restore ocular blood flow and improve visual acuity. The objective of the current report was to present the use of prostaglandin E 1 (PGE1) - a powerful vasodilator of the microcirculation - in the treatment of AAION. Two patients with AAION were treated with intravenous steroids and PGE1. The visual acuity improved from 4/50 (less than 20/200) to 6/10 (20/35) in one patient and from 1/50 (20/400) to 1/10 (20/200) in the second patient. The visual fields in both patients maintained small central islands of vision. No complications due to the use of PGE 1 were seen. Intravenous PGE1 should be considered in addition to steroids in cases of AAION to immediately restore blood flow to the optic nerve and improve visual acuity while the steroids reduce the inflammation.

KW - AAION

KW - Arteritic anterior ischemic optic neuropathy

KW - Giant cell arteritis

KW - PGE

KW - Prostaglandin E

UR - http://www.scopus.com/inward/record.url?scp=80053025982&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053025982&partnerID=8YFLogxK

U2 - 10.1055/s-0031-1278380

DO - 10.1055/s-0031-1278380

M3 - Article

VL - 19

JO - International Journal of Angiology

JF - International Journal of Angiology

SN - 1061-1711

IS - 3

ER -